ITP - IMMUNE THROMBOCYTOPENIA
Clinical trials for ITP - IMMUNE THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new ITP - IMMUNE THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for ITP - IMMUNE THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to help teens with rare bleeding disorder
Disease control Recruiting nowThis study is testing a drug called efgartigimod in teenagers (12 to under 18 years old) who have chronic immune thrombocytopenia (ITP), a condition where the immune system attacks blood platelets. The main goal is to find the correct dose and see if it helps increase and maintai…
Matched conditions: ITP - IMMUNE THROMBOCYTOPENIA
Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
New drug tested for patients whose immune systems attack their own blood
Disease control Recruiting nowThis early-stage trial is testing a new injectable drug called OM336 in adults whose immune systems mistakenly destroy their own red blood cells or platelets. The main goal is to check if the drug is safe and well-tolerated in people who have not fully responded to at least one p…
Matched conditions: ITP - IMMUNE THROMBOCYTOPENIA
Phase: PHASE1 • Sponsor: Ouro Medicines • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC